Smital Shah

Smital Shah currently holds the position of Consulting Chief Business Officer at Centrexion Therapeutics Corp. and Consulting Chief Financial Officer at Bitterroot Bio, both roles starting in late 2023. Additionally, Smital Shah serves as Managing Partner at Amaid Lifesciences/Biotech Advisory since January 2022, providing CEO/CBO/CFO advisory services. Shah is also a member of the Board of Directors for Pliant Therapeutics and Graphite Bio. Previous experience includes the Consulting Chief Financial Officer role at Mirum Pharmaceuticals, service as Chief Business & Financial Officer and Chief Financial Officer at ProQR Therapeutics, and contributions in Corporate Treasury at Gilead Sciences. Earlier career positions were held at Leerink Swann and JPMorgan in healthcare investment banking. Smital Shah possesses an MBA in Finance from the University of California, Berkeley, an MS in Chemical Engineering from Virginia Tech, and a BS in Chemical Engineering from the University of Mumbai.